Document is current
Any future updates will be listed below
-
Authors
Loh, Nellie Y. https://orcid.org/0000-0002-5979-9019
Minchin, James E. N. https://orcid.org/0000-0003-2316-1010
Pinnick, Katherine E. https://orcid.org/0000-0002-2422-248X
Verma, Manu https://orcid.org/0000-0002-5689-2808
Todorčević, Marijana
Denton, Nathan https://orcid.org/0000-0001-7915-4392
Moustafa, Julia El-Sayed https://orcid.org/0000-0001-6963-6654
Kemp, John P.
Gregson, Celia L. https://orcid.org/0000-0001-6414-0529
Evans, David M. https://orcid.org/0000-0003-0663-4621
Neville, Matt J. https://orcid.org/0000-0002-6004-5433
Small, Kerrin S. https://orcid.org/0000-0003-4566-0005
McCarthy, Mark I.
Mahajan, Anubha
Rawls, John F. https://orcid.org/0000-0002-5976-5206
Karpe, Fredrik
Christodoulides, Constantinos https://orcid.org/0000-0001-5154-0785
-
Funding
Funding for this research was provided by:
British Heart Foundation (FS/16/45/32359, PG/12/78/29862)
University of Edinburgh
Versus Arthritis
RCUK | Medical Research Council (MR/L01999X/1, MR/M004422/1, M004422/1, L0201491/1, J010642/1)
Wellcome Trust (090532, 203141, 106130, 098381, 212259)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (U01DK105535)
Heart Research UK
DH | NIHR | Programme Grants for Applied Research (R01-DK093399)
European Association for the Study of Diabetes
- License Information
-
More Information
Article History
Received: 4 November 2019
Accepted: 7 May 2020
First Online: 3 June 2020
Competing interests
: C.C. and F.K. have received funding from NovoNordisk and Takeda. M.I.McC. was a Wellcome Senior Investigator and an NIHR Senior Investigator. M.I.McC. has served on advisory panels for Pfizer, NovoNordisk, Zoe Global; has received honoraria from Merck, Pfizer, NovoNordisk and Eli Lilly; has stock options in Zoe Global and has received research funding from Abbvie, Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Merck, NovoNordisk, Pfizer, Roche, Sanofi Aventis, Servier & Takeda. As of June 2019, M.I.McC. is an employee of Genentech, and holds stock in Roche.
